WebDisclosure WebDisclosure
Basculer en Français
10603 Companies
225009 Keywords
153732 Articles
119071 Press releases
Headlines Articles Press releases ScriptDrop Remove
  1. Home
  2. Companies
  3. ScriptDrop
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 02/27/2024 at 16:00, 2 years 3 months ago

    ScriptDrop et Louvir s'associent pour améliorer l'accès aux médicaments

    ScriptDrop Louvir Accès Aux Médicaments Livraison De Prescriptions Programme 340B
  • BRIEF

    published on 02/27/2024 at 16:00, 2 years 3 months ago

    ScriptDrop and Louvir partner to improve access to medicines

    ScriptDrop Louvir Access To Medicines Prescription Delivery 340B Program
  • PRESS RELEASE

    published on 02/27/2024 at 16:00, 2 years 3 months ago

    ScriptDrop Inc. and Louvir Partner to Simplify Prescription Access for Patients

    ScriptDrop, Inc. partners with Louvir to provide same-day and next-day prescription delivery, improving medication access for 340B patients. Partnership aims to boost medication adherence and revenue
    Louvir Prescription Delivery ScriptDrop Inc. Medication Access 340B Patients
    Logo of ScriptDrop
Accesswire
  • Published on 06/20/2026 at 01:00, 12 hours 22 minutes ago

    Onco-Innovations Announces Non-Brokered LIFE Offering

  • Published on 06/20/2026 at 00:00, 13 hours 22 minutes ago

    Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development

  • Published on 06/19/2026 at 04:30, 1 day 8 hours ago

    Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp

  • Published on 06/19/2026 at 01:20, 1 day 12 hours ago

    American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting

  • Published on 06/19/2026 at 01:07, 1 day 12 hours ago

    Usha Resources Announces Share Issuance in Payment of Debenture Interest, Adopts Semi-Annual Reporting

View all ACCESSWIRE
EQS Group
  • Published on 06/20/2026 at 06:00, 7 hours 22 minutes ago

    Successful debut of International Symposium on Emergency Response and Aeromedical Services in Hong Kong

  • Published on 06/19/2026 at 20:17, 17 hours 4 minutes ago

    2CRSi SA: 2CRSi Responds Point-by-Point to the Grizzly Research Report and Reaffirms the Reality of Its Business Operations

  • Published on 06/19/2026 at 20:17, 17 hours 4 minutes ago

    2CRSi SA: 2CRSi répond point par point au rapport de Grizzly Research et réaffirme la réalité de son activité

  • Published on 06/19/2026 at 19:01, 18 hours 21 minutes ago

    Fuller, Smith & Turner PLC: Publication of the Annual Report and Accounts for the 52 weeks ending 28 March 2026 and Notice of 2026 Annual General Meeting

  • Published on 06/19/2026 at 18:29, 18 hours 53 minutes ago

    Designated Person Notification

View all EQS
Les Echos
  • Published on 06/19/2026 at 19:33, 17 hours 49 minutes ago

    Déclaration hebdomadaire d'opérations effectuées du 15 au 19 juin 2026

  • Published on 06/19/2026 at 19:33, 17 hours 49 minutes ago

    Disclosure of transactions in own shares from June 15 to June 19, 2026

  • Published on 06/19/2026 at 19:23, 17 hours 58 minutes ago

    Imerys-06-2026-communique-capital-droits-de-vote-au-31-mai-2026

  • Published on 06/19/2026 at 19:23, 17 hours 58 minutes ago

    Imerys-06-2026-information-share-capital-and-voting-rights-as-of-31-May-2026

  • Published on 06/19/2026 at 19:05, 18 hours 17 minutes ago

    CP - Changement de gouvernance

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy